MiR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma

Oncogene

Volumn 34, Issue 8, 2015, Pages 965-977

  Zhou, X ^a,b   Zhang, C Z ^a   Lu, S X ^a   Chen, G G ^c   Li, L Z ^a   Liu, L L ^a   Yi, C ^a   Fu, J ^a   Hu, W ^a   Wen, J M ^b   Yun, J P ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

IMP-1 PROTEIN, HUMAN; MICRORNA; MIRN625 MICRORNA, HUMAN; RNA BINDING PROTEIN;

ADULT; AGED; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE; TUMOR INVASION; TUMOR SUPPRESSOR GENE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; RNA-BINDING PROTEINS; TUMOR CELLS, CULTURED;

EID: 84895914554     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.35     Document Type: Article

References (35)

1. Forner A, Hessheimer AJ, Isabel RM, Bruix J. Treatment of hepatocellular carcinoma. Crit Rev Oncol Hematol 2006; 60: 89-98.
2. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576.
3. Aravalli RN, Steer CJ, Cressman EN. Molecular mechanisms of hepatocellular carcinoma. Hepatology 2008; 48: 2047-2063.
4. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
5. Negrini M, Nicoloso MS, Calin GA. MicroRNAs and cancer-new paradigms in molecular oncology. Curr Opin Cell Biol 2009; 21: 470-479.
6. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAsmodulate E2F1 expression. Nature 2005; 435: 839-843.
7. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007; 67: 6092-6099.
8. Shimizu S, Takehara T, Hikita H, Kodama T, Miyagi T, Hosui A et al. The let-7 family of microRNAsinhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 2010; 52: 698-704.
9. Yao J, Liang L, Huang S, Ding J, Tan N, Zhao Y et al. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology 2010; 51: 846-856.
10. Wong CC, Wong CM, Tung EK, Au SL, Lee JM, Poon RT et al. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology 2011; 140: 322-331.
11. Tan S, Li R, Ding K, Lobie PE, Zhu T. miR-198 inhibits migration andinvasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway. FEBS Lett 2011; 585: 2229-2234.
12. Yaniv K, Yisraeli JK. The involvement of a conserved family of RNA binding proteins in embryonic development and carcinogenesis. Gene 2002; 287: 49-54.
13. Yisraeli JK. VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. Biol Cell 2005; 97: 87-96.
14. Huttelmaier S, Zenklusen D, Lederer M, Dictenberg J, Lorenz M, Meng X et al. Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1. Nature 2005; 438: 512-515.
15. Kobel M, Weidensdorfer D, Reinke C, Lederer M, Schmitt WD, Zeng K et al. Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma. Oncogene 2007; 26: 7584-7589.
16. Vainer G, Vainer-Mosse E, Pikarsky A, Shenoy SM, Oberman F, Yeffet A et al. A role for VICKZ proteins in the progression of colorectal carcinomas: regulating lamellipodia formation. J Pathol 2008; 215: 445-456.
17. Li LZ, Zhang CZ, Liu LL, Yi C, Lu SX, Zhou X et al. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1. Carcinogenesis 2013; 35: 469-478.
18. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007; 129: 1401-1414.
19. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
20. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
21. Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001; 7: 445-454.
22. Zhang X, Liu S, Hu T, He Y, Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009; 50: 490-499.
23. Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 2009; 49: 1571-1582.
24. Yan Y, Luo YC, Wan HY, Wang J, Zhang PP, Liu M et al. MicroRNA-10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4-mediated epithelial-mesenchymal transitionand adhesion in hepatoma cells. Hepatology 2013; 57: 667-677.
25. Oberman F, Rand K, Maizels Y, Rubinstein AM, Yisraeli JK. VICKZ proteins mediate cell migration via their RNA binding activity. RNA 2007; 13: 1558-1569.
26. Ross AF, Oleynikov Y, Kislauskis EH, Taneja KL, Singer RH. Characterization of a beta-actin mRNA zipcode-binding protein. Mol Cell Biol 1997; 17: 2158-2165.
27. Leung KM, van Horck FP, Lin AC, Allison R, Standart N, Holt CE. Asymmetrical beta-actin mRNA translation in growth cones mediates attractive turning to netrin-1. Nat Neurosci 2006; 9: 1247-1256.
28. Yao J, Sasaki Y, Wen Z, Bassell GJ, Zheng JQ. An essential role for beta-actin mRNA localization and translation in Ca2+-dependent growth cone guidance. Nat Neurosci 2006; 9: 1265-1273.
29. Lapidus K, Wyckoff J, Mouneimne G, Lorenz M, Soon L, Condeelis JS et al. ZBP1 enhances cell polarity and reduces chemotaxis. J Cell Sci 2007; 120: 3173-3178.
30. Vikesaa J, Hansen TV, Jonson L, Borup R, Wewer UM, Christiansen J et al. RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J 2006; 25: 1456-1468.
31. Stohr N, Kohn M, Lederer M, Glass M, Reinke C, Singer RH et al. IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling. Genes Dev 2012; 26: 176-189.
32. Read DE, Gorman AM. Heat shock protein 27 in neuronal survival and neurite outgrowth. Biochem Biophys Res Commun 2009; 382: 6-8.
33. Read DE, Gorman AM. Involvement of Akt in neurite outgrowth. Cell Mol Life Sci 2009; 66: 2975-2984.
34. During RL, Gibson BG, Li W, Bishai EA, Sidhu GS, Landry J et al. Anthrax lethal toxin paralyzes actin-based motility by blocking Hsp27 phosphorylation. EMBO J 2007; 26: 2240-2250.
35. Ioannidis P, Mahaira LG, Perez SA, Gritzapis AD, Sotiropoulou PA, Kavalakis GJ et al. CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells. J Biol Chem 2005; 280: 20086-20093.